Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NuSepin in COVID-19 Pneumonia
NCT04565379Phase 2Completed
- Sponsor
- Shaperon
- Start
- Sep 2020
- Primary completion
- Apr 2021
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hy209gel in COVID-19 pneumonia, sponsored by Shaperon. Started Sep 2020; status: completed.
02
Drugs
hy209gel
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04565379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04565379.